1. Home
  2. EYPT vs NSSC Comparison

EYPT vs NSSC Comparison

Compare EYPT & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$11.92

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$36.37

Market Cap

1.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
NSSC
Founded
1987
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Telecommunications Equipment
Sector
Industrials
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2005
1994

Fundamental Metrics

Financial Performance
Metric
EYPT
NSSC
Price
$11.92
$36.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$31.80
$48.17
AVG Volume (30 Days)
1.5M
268.7K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
1.33%
EPS Growth
N/A
N/A
EPS
N/A
0.70
Revenue
$7,539,000.00
$181,621,000.00
Revenue This Year
N/A
$13.63
Revenue Next Year
$3,115.57
$10.05
P/E Ratio
N/A
$53.14
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$29.27
52 Week High
$19.11
$47.61

Technical Indicators

Market Signals
Indicator
EYPT
NSSC
Relative Strength Index (RSI) 36.19 47.95
Support Level $9.65 $34.25
Resistance Level $13.32 $36.88
Average True Range (ATR) 0.81 0.92
MACD -0.23 0.08
Stochastic Oscillator 3.24 53.70

Price Performance

Historical Comparison
EYPT
NSSC

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: